Results
|
1101.
|
Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells. [electronic resource] by
- Bonet, Caroline
- Giuliano, Sandy
- Ohanna, Mickaël
- Bille, Karine
- Allegra, Maryline
- Lacour, Jean-Philippe
- Bahadoran, Philippe
- Rocchi, Stéphane
- Ballotti, Robert
- Bertolotto, Corine
Producer: 20121119
In:
The Journal of biological chemistry vol. 287
Availability: No items available.
|
|
1102.
|
|
|
1103.
|
|
|
1104.
|
|
|
1105.
|
FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells. [electronic resource] by
- Lin, Jing
- Ji, Aihui
- Qiu, Guanzhong
- Feng, Huaizhi
- Li, Jian
- Li, Shuo
- Zou, Yongxiang
- Cui, Yong
- Song, Chaoli
- He, Hua
- Lu, Yicheng
Producer: 20180416
In:
Cancer science vol. 109
Availability: No items available.
|
|
1106.
|
Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer. [electronic resource] by
- Bonazzoli, Elena
- Predolini, Federica
- Cocco, Emiliano
- Bellone, Stefania
- Altwerger, Gary
- Menderes, Gulden
- Zammataro, Luca
- Bianchi, Anna
- Pettinella, Francesca
- Riccio, Francesco
- Han, Chanhee
- Yadav, Ghanshyam
- Lopez, Salvatore
- Manzano, Aranzazu
- Manara, Paola
- Buza, Natalia
- Hui, Pei
- Wong, Serena
- Litkouhi, Babak
- Ratner, Elena
- Silasi, Dan-Arin
- Huang, Gloria S
- Azodi, Masoud
- Schwartz, Peter E
- Schlessinger, Joseph
- Santin, Alessandro D
Producer: 20191210
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|
|
1107.
|
|
|
1108.
|
|
|
1109.
|
Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases. [electronic resource] by
- Matsuhashi, A
- Ohno, T
- Kimura, M
- Hara, A
- Saio, M
- Nagano, A
- Kawai, G
- Saitou, M
- Takigami, I
- Yamada, K
- Okano, Y
- Shimizu, K
Producer: 20121003
In:
Current cancer drug targets vol. 12
Availability: No items available.
|
|
1110.
|
|
|
1111.
|
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders. [electronic resource] by
- Dawson, Mark A
- Curry, Jayne E
- Barber, Kelly
- Beer, Philip A
- Graham, Brent
- Lyons, John F
- Richardson, Caroline J
- Scott, Mike A
- Smyth, Tomoko
- Squires, Matthew S
- Thompson, Neil T
- Green, Anthony R
- Wallis, Nicola G
Producer: 20100901
In:
British journal of haematology vol. 150
Availability: No items available.
|
|
1112.
|
|
|
1113.
|
|
|
1114.
|
|
|
1115.
|
|
|
1116.
|
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. [electronic resource] by
- Faisal, Amir
- Vaughan, Lynsey
- Bavetsias, Vassilios
- Sun, Chongbo
- Atrash, Butrus
- Avery, Sian
- Jamin, Yann
- Robinson, Simon P
- Workman, Paul
- Blagg, Julian
- Raynaud, Florence I
- Eccles, Suzanne A
- Chesler, Louis
- Linardopoulos, Spiros
Producer: 20120315
In:
Molecular cancer therapeutics vol. 10
Availability: No items available.
|
|
1117.
|
|
|
1118.
|
|
|
1119.
|
|
|
1120.
|
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. [electronic resource] by
- Gontarewicz, Artur
- Balabanov, Stefan
- Keller, Gunhild
- Colombo, Riccardo
- Graziano, Alessio
- Pesenti, Enrico
- Benten, Daniel
- Bokemeyer, Carsten
- Fiedler, Walter
- Moll, Jürgen
- Brümmendorf, Tim H
Producer: 20080513
In:
Blood vol. 111
Availability: No items available.
|